The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785753/
https://www.ncbi.nlm.nih.gov/pubmed/29315294
http://dx.doi.org/10.1038/bjc.2017.418
_version_ 1783295665138302976
author Shroff, Rachna T
Yarchoan, Mark
O'Connor, Ashley
Gallagher, Denise
Zahurak, Marianna L
Rosner, Gary
Ohaji, Chimela
Sartorius-Mergenthaler, Susan
Parkinson, Rose
Subbiah, Vivek
Zinner, Ralph
Azad, Nilofer S
author_facet Shroff, Rachna T
Yarchoan, Mark
O'Connor, Ashley
Gallagher, Denise
Zahurak, Marianna L
Rosner, Gary
Ohaji, Chimela
Sartorius-Mergenthaler, Susan
Parkinson, Rose
Subbiah, Vivek
Zinner, Ralph
Azad, Nilofer S
author_sort Shroff, Rachna T
collection PubMed
description
format Online
Article
Text
id pubmed-5785753
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57857532018-02-01 The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma Shroff, Rachna T Yarchoan, Mark O'Connor, Ashley Gallagher, Denise Zahurak, Marianna L Rosner, Gary Ohaji, Chimela Sartorius-Mergenthaler, Susan Parkinson, Rose Subbiah, Vivek Zinner, Ralph Azad, Nilofer S Br J Cancer Corrigendum Nature Publishing Group 2018-01 2018-01-09 /pmc/articles/PMC5785753/ /pubmed/29315294 http://dx.doi.org/10.1038/bjc.2017.418 Text en Copyright © 2018 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Corrigendum
Shroff, Rachna T
Yarchoan, Mark
O'Connor, Ashley
Gallagher, Denise
Zahurak, Marianna L
Rosner, Gary
Ohaji, Chimela
Sartorius-Mergenthaler, Susan
Parkinson, Rose
Subbiah, Vivek
Zinner, Ralph
Azad, Nilofer S
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title_full The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title_fullStr The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title_full_unstemmed The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title_short The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
title_sort oral vegf receptor tyrosine kinase inhibitor pazopanib in combination with the mek inhibitor trametinib in advanced cholangiocarcinoma
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785753/
https://www.ncbi.nlm.nih.gov/pubmed/29315294
http://dx.doi.org/10.1038/bjc.2017.418
work_keys_str_mv AT shroffrachnat theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT yarchoanmark theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT oconnorashley theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT gallagherdenise theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT zahurakmariannal theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT rosnergary theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT ohajichimela theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT sartoriusmergenthalersusan theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT parkinsonrose theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT subbiahvivek theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT zinnerralph theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT azadnilofers theoralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT shroffrachnat oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT yarchoanmark oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT oconnorashley oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT gallagherdenise oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT zahurakmariannal oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT rosnergary oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT ohajichimela oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT sartoriusmergenthalersusan oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT parkinsonrose oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT subbiahvivek oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT zinnerralph oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma
AT azadnilofers oralvegfreceptortyrosinekinaseinhibitorpazopanibincombinationwiththemekinhibitortrametinibinadvancedcholangiocarcinoma

Ejemplares similares